Rapid Itch Improvement and Skin Clearance with Upadacitinib Versus Placebo (Measure Up 1 and Measure Up 2) and Versus Dupilumab (Heads Up): Results from Three Phase 3 Clinical Trials in Patients with Moderate-to-Severe Atopic Dermatitis.
Saved in:
| Title: | Rapid Itch Improvement and Skin Clearance with Upadacitinib Versus Placebo (Measure Up 1 and Measure Up 2) and Versus Dupilumab (Heads Up): Results from Three Phase 3 Clinical Trials in Patients with Moderate-to-Severe Atopic Dermatitis. |
|---|---|
| Authors: | Simpson, Eric L.1 (AUTHOR) simpsone@ohsu.edu, Silverberg, Jonathan I.2 (AUTHOR), Prajapati, Vimal H.3,4,5,6,7 (AUTHOR), Eyerich, Kilian8 (AUTHOR), Katoh, Norito9 (AUTHOR), Boguniewicz, Mark10,11 (AUTHOR), Guttman-Yassky, Emma12 (AUTHOR), Song, E. James13 (AUTHOR), Lee, Wan-Ju14 (AUTHOR), Teixeira, Henrique D.14 (AUTHOR), Wu, Tianshuang14 (AUTHOR), Sancho Sanchez, Cristina14 (AUTHOR), Vigna, Namita14 (AUTHOR), Calimlim, Brian M.14 (AUTHOR), de Bruin-Weller, Marjolein15 (AUTHOR) |
| Source: | Dermatology & Therapy. Aug2025, Vol. 15 Issue 8, p2061-2076. 16p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
